arrow
F

Farsad Eskandary

Medical University of Vienna
H指数:36
被引数:4,498

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

DARC and Anti-Duffy Antibodies in the Line of Fire: The Challenges in Pinpointing the Etiology of Microcirculation Inflammation to a Distinct Entity

DARC和抗 Duffy 抗体在炎症前沿:将微循环炎症的病因明确归因于特定实体的挑战

2026-01-120
OA
Plasma aldosterone is low in patients hospitalized with COVID-19 and not associated with changes in serum potassium levels: post hoc observational analyses of clinical trial data

COVID-19住院患者的血浆醛固酮水平较低,且与血清钾水平的变化无关:临床试验数据的后验观察性分析

2025-12-100
OAAI
Prevalence of Strongyloides stercoralis in haemodialysis patients in Vienna

嗜酸性丝虫在维也纳血液透析患者中的流行率

2025-10-010
OAAI
Immunoadsorption as a novel therapy for refractory idiopathic inflammatory myopathies: a retrospective observational study

免疫吸附作为难治性特发性炎性肌病的一种新型疗法:一项回顾性观察性研究

2025-06-010
OA
Randomized phase 2 trial of felzartamab in humoral transplant rejection.
2024-09-160
PRE
A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection
2024-07-1114
PRE
Polyomavirus Nephropathy in ABO Blood Group-Incompatible Kidney Transplantation: Torque Teno Virus and Immunosuppressive Burden as an Approximation to the Problem
2024-06-012
OAAI
The systemic renin-angiotensin system in COVID-19
2022-11-2217
OAAI
Stopping of Mycophenolic Acid in Kidney Transplant Recipients for 2 Weeks Peri-Vaccination Does Not Increase Response to SARS-CoV-2 Vaccination-A Non-randomized, Controlled Pilot Study

在肾移植受者中停止霉酚酸2周围期疫苗接种不会增加对SARS-CoV-2疫苗接种的反应-一项非随机,对照的初步研究

2022-06-1023
OAAI
Early Estimated Glomerular Filtration Rate Trajectories After Kidney Transplant Biopsy as a Surrogate Endpoint for Graft Survival in Late Antibody-Mediated Rejection
2022-04-215
OAAI